Sanofi | SAN - Des Atouts





Des Atouts Changement Date
AbbVie USD 135.12B 1.35B 2026-06
Aena EUR 18.8B 393.25M 2026-06
Alcon AG USD 31.62B 64M 2026-03
Almirall EUR 2.37B 29.97M 2026-06
Amarin USD 624.36M 21.4M 2026-06
Amgen USD 95.64B 3.14B 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Bayer EUR 107.94B 3.4B 2026-03
Biogen USD 32.09B 2.6B 2026-06
BMW EUR 270.62B 4.66B 2026-03
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Eli Lilly USD 116.58B 4.1B 2026-03
Essilor EUR 65.06B 1.16B 2026-06
Fresenius EUR 41.4B 1.07B 2025-12
Fresenius Medical Care EUR 31.47B 465.26M 2026-03
Genmab DKK 12.87B 5.85B 2025-12
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
GRIFOLS EUR 20.09B 12M 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
J&J USD 201.06B 167M 2026-06
Lakefront Biotherapeutics EUR 3.37B 34.09M 2026-03
Lonza CHF 18.97B 164M 2025-12
Mercedes-Benz AG EUR 259.72B 1.1B 2026-06
Merck EUR 53.07B 1.54B 2026-03
Merck USD 128.68B 8.18B 2026-03
Novartis USD 122.03B 3.5B 2026-06
Novo Nordisk DKK 559.22B 16.32B 2026-03
Orion EUR 1.87B 205.5M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Philips EUR 26.7B 565M 2026-06
Recordati EUR 5.37B 33.76M 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Sanofi EUR 128.02B 1.22B 2026-03
SAP EUR 75.61B 2.15B 2026-06
UCB EUR 18.16B 971M 2025-12
Vinci EUR 134.87B 1.8B 2026-06
Volkswagen EUR 669.35B 3.27B 2026-06